Refine
Has Fulltext
- yes (7)
Is part of the Bibliography
- yes (7)
Document Type
- Journal article (6)
- Doctoral Thesis (1)
Keywords
- meta-analysis (2)
- BM (1)
- Bronchialkarzinom (1)
- CRC (1)
- Germany (1)
- LAMN (1)
- LND (1)
- LNE (1)
- NSCLC (1)
- Retrosepektiv (1)
- SSI (1)
- TKI (1)
- ZfKD (1)
- acute appendicitis (1)
- adrenal cancer (1)
- adrenocortical carcinoma (1)
- antibiotics (1)
- appendectomy (1)
- appendicitis (1)
- appendix (1)
- brain metastases (1)
- cerebral metastases (1)
- colorectal cancer (1)
- conventional laparoscopic appendectomy (1)
- epidemiology (1)
- laparoscopic appendectomy (1)
- low-grade mucinous neoplasm (1)
- lymph node dissection (1)
- lymphadenectomy (1)
- open appendectomy (1)
- pediatric adrenocortical adenoma (1)
- pediatric adrenocortical cancer (1)
- pediatric adrenocortical tumor (1)
- prognostic factors (1)
- review (1)
- single-port appendectomy (1)
- surgical site infection (1)
- systematic review (1)
- therapy (1)
- wound infection (1)
Institute
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (6)
- Comprehensive Cancer Center Mainfranken (5)
- Theodor-Boveri-Institut für Biowissenschaften (5)
- Kinderklinik und Poliklinik (2)
- Medizinische Klinik und Poliklinik I (2)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (1)
- Medizinische Fakultät (1)
Adrenocortical tumors are rare in children. This systematic review summarizes the published evidence on pediatric adrenocortical carcinoma (ACC) to provide a basis for a better understanding of the disease, investigate new molecular biomarkers and therapeutic targets, and define which patients may benefit from a more aggressive therapeutic approach. We included 137 studies with 3680 ACC patients (~65% female) in our analysis. We found no randomized controlled trials, so this review mainly reflects retrospective data. Due to a specific mutation in the TP53 gene in ~80% of Brazilian patients, that cohort was analyzed separately from series from other countries. Hormone analysis was described in 2569 of the 2874 patients (89%). Most patients were diagnosed with localized disease, whereas 23% had metastasis at primary diagnosis. Only 72% of the patients achieved complete resection. In 334 children (23%), recurrent disease was reported: 81% — local recurrence, 19% (n = 65) — distant metastases at relapse. Patients < 4 years old had a different distribution of tumor stages and hormone activity and better overall survival (p < 0.001). Although therapeutic approaches are typically multimodal, no consensus is available on effective standard treatments for advanced ACC. Thus, knowledge regarding pediatric ACC is still scarce and international prospective studies are needed to implement standardized clinical stratifications and risk-adapted therapeutic strategies.